SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-031749
Filing Date
2024-06-28
Accepted
2024-06-28 16:05:20
Documents
15
Period of Report
2024-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20031912_8k.htm   iXBRL 8-K 30421
2 EXHIBIT 99.1 ef20031912_ex99-1.htm EX-99.1 18764
6 image00001.jpg GRAPHIC 4315
  Complete submission text file 0001140361-24-031749.txt   197563

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rckt-20240628.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20240628_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20240628_pre.xml EX-101.PRE 16052
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20031912_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 241085653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)